單細胞分析市場規模、佔有率、成長分析，按類型、應用、地區分類 - 產業預測，2024-2031 年

2022年全球單細胞分析市場規模為32億美元，從2023年的36.3億美元成長到2031年的100億美元，預計複合年成長率為13.50%。

全球單細胞分析市場正在經歷強勁成長，預計在不久的將來將進一步擴大。該領域在癌症研究、免疫學、神經科學和幹細胞生物學等多個研究領域中變得越來越重要。這一成長的主要驅動力是對個人化醫療的需求不斷成長。基因組學和分子生物學的進展強調，組織和生物體內的單一細胞可以表現出各種不同的特徵和反應。這種認知正在推動向標靶治療和精準醫學的轉變，其中分析單細胞可以為為個別患者量身定做治療提供重要的見解。檢查單一細胞的能力有助於識別疾病特異性生物標記、了解疾病進展並開發有效的治療方法。因此，市場對單細胞分析技術和解決方案的需求不斷增加。流式細胞技術、次世代定序、質譜流式細胞儀和單細胞 PCR 等技術透過實現細胞特性和功能的高解析度分析，正在徹底改變該領域，進一步推動市場擴張。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 貿易分析
• 供應鏈分析
• 案例研究分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

單細胞分析市場：按產品

• 市場概況
• 消耗品
  • 珠子、微孔盤
  • 試劑
  • 檢測試劑套件
  • 免疫檢測
  • 基於細胞的檢測
  • 其他消耗品
• 裝置
  • 流式細胞儀
  • NGS系統
  • PCR設備
  • 光強度
  • 細胞計數器
  • 顯微鏡
  • HCS系統
  • 微陣列
  • 其他樂器

單細胞分析市場：依細胞類型

• 市場概況
• 人體細胞
• 動物細胞
• 微生物細胞

單細胞分析市場：依方法分類

• 市場概況
• 流式細胞技術
• 次世代定序
• 聚合酵素鏈鎖反應
• 顯微鏡檢查
• 質譜分析
• 其他技術

單細胞分析市場：依應用分類

• 市場概況
• 研究用途
  • 癌症研究
  • 免疫學研究
  • 神經學研究
  • 幹細胞研究
  • 其他研究用途
• 醫療用途
  • 非侵入性產前診斷
  • 體外受精
  • 循環性腫瘤細胞的檢測

單細胞分析市場：依最終用戶分類

• 市場概況
• 學術研究所
• 生物技術和製藥公司
• 醫院和診斷實驗室
• 細胞庫和IVF中心

單細胞分析市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• BD（US）
• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• 10x Genomics（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• Qiagen（Germany）
• Illumina, Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Diasorin SPA（Italy）
• Standard Biotools（US）
• Tecan Trading AG（Switzerland）
• Sartorius AG（Germany）
• Corning Incorporated（US）
• Cytek Biosciences（US）
• Takara Bio Inc.（Japan）
• Biomerieux（France）
• Revvity（US）
• Bio-Techne（US）
• Pacbio（US）
• Bruker（US）
• Promega Corporation（US）
• Oxford Nanopore Technologies Plc（UK）
• Singleron Biotechnologies（China）
• Cell Microsystems（US）
• Nanocellect Biomedical（US）
• Rarecyte, Inc.（US）
• Bico（Sweden）
• Menarini Group（Italy）

Global Single Cell Analysis Market size was valued at USD 3.20 billion in 2022 and is poised to grow from USD 3.63 billion in 2023 to USD 10.00 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The global market for single-cell analysis is experiencing robust growth and is set for further expansion in the near future. This field is becoming increasingly significant across various research areas including cancer research, immunology, neuroscience, and stem cell biology. A major driver of this growth is the rising demand for personalized medicine. Advances in genomics and molecular biology have highlighted that individual cells within a tissue or organism can display a range of distinct characteristics and responses. This realization is pushing the shift towards targeted therapies and precision medicine, where analyzing single cells provides critical insights for customizing treatments to individual patients. The ability to examine individual cells has been instrumental in identifying disease-specific biomarkers, understanding disease progression, and developing effective therapies. As a result, there is a growing market demand for single-cell analysis technologies and solutions. Techniques such as flow cytometry, next-generation sequencing, mass cytometry, and single-cell PCR have transformed the field by enabling high-resolution analysis of cellular characteristics and functions, further fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Cell Analysis Market Segmental Analysis

Global Single Cell Analysis Market is segmented by Product, Cell Type, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, Animal Cells, and Microbial Cells. Based on Technique, the market is segmented into Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, and Other Techniques. Based on Application, the market is segmented into Research Applications, Medical Applications. Based on End User, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Single Cell Analysis Market

Stem cell biology is undergoing a major research boost due to the promising therapeutic potential of stem cells. Single-cell analysis is crucial in this field as it allows for the detailed characterization and manipulation of stem cells at the individual cell level. This approach enables researchers to identify and isolate specific stem cell populations, monitor their differentiation processes, and assess their functional attributes. As interest in stem cell biology grows, there is an increasing demand for sophisticated single-cell analysis tools and technologies to support these advancements.

Restraints in the Global Single Cell Analysis Market

Single-cell analysis faces significant challenges due to its inherent complexity and high costs. The techniques involved often demand specialized equipment, skilled operators, and meticulously defined workflows, which can complicate their implementation. This complexity can limit the widespread adoption of single-cell analysis, especially in resource-constrained environments where advanced infrastructure and expertise are scarce. Additionally, the financial burden associated with acquiring and maintaining the necessary equipment and reagents for single-cell analysis can be prohibitive for smaller research labs and institutions. These cost and complexity issues create barriers that need to be addressed to make single-cell analysis more accessible and affordable across diverse research settings.

Market Trends of the Global Single Cell Analysis Market

A notable trend in the single-cell analysis market is the growing adoption of spatial transcriptomics. This advanced technique enables researchers to visualize and analyze gene expression patterns across entire tissues, providing valuable insights into cellular organization. By mapping gene activity in situ, spatial transcriptomics helps identify various cell types and subtypes, as well as elucidate cellular interactions within their native environments. This approach enhances our understanding of tissue architecture and cellular dynamics, offering a deeper perspective on how cells communicate and function collectively. As a result, spatial transcriptomics is becoming increasingly integral to research efforts aimed at unraveling complex biological processes and disease mechanisms.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Single Cell Analysis Market by Product

• Market Overview
• Consumables
  • Beads, Microplates
  • Reagents
  • Assay Kits
  • Immunoassays
  • Cell-Based Assays
  • Other Consumables
• Instruments
  • Flow Cytometers
  • NGS Systems
  • PCR Instruments
  • Spectrophotometers
  • Cell Counters
  • Microscopes
  • HCS Systems
  • Microarrays
  • Other Instruments

Single Cell Analysis Market by Cell Type

• Market Overview
• Human Cells
• Animal Cells
• Microbial Cells

Single Cell Analysis Market by Technique

• Market Overview
• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
• Other Techniques

Single Cell Analysis Market by Application

• Market Overview
• Research Applications
  • Cancer Research
  • Immunology Research
  • Neurology Research
  • Stem Cell Research
  • Other Research Applications
• Medical Applications
  • Non-Invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection

Single Cell Analysis Market by End User

• Market Overview
• Academic & Research Laboratories
• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Cell Banks & IVF Centers

Single Cell Analysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin S.P.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Biotools (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytek Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacbio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singleron Biotechnologies (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Microsystems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanocellect Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rarecyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bico (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments